Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Hamas hands over another body in the Gaza Strip - 2What you need to know about flu treatments as cases spike across the US
- 3Greece eyes migrant repatriation centres outside the EU
- 4Insurance warning signs in doctors’ offices might discourage patients from speaking openly about their health
- 5Tire Brands for Senior Drivers: Guaranteeing Security and Solace
- 7 Strange Devices to Make Your Party Stick Out!
- The most effective method to Distinguish the Best Material Organization in Your Space
- France will build a new aircraft carrier as it increases defense spending
- 7 Peculiar Ways Of starting Your Imagination: Motivation Has Never Been This Good times
- Nations for Rock Climbing
- How did life begin on Earth? New experiments support 'RNA world' hypothesis
- The Tiny Channel Island With 65 Residents That Chefs And Foodies Go Out Of Their Way To Visit
- Google to Use Natural Gas to Power Massive Data Center in Texas
- IDF: Staying in West Bank refugee camps will quell lone-wolf terror
